Rhenman & Partners Asset Management AB - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 131 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
Rhenman & Partners Asset Management AB ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q1 2018$1,236,000
-12.0%
302,1570.0%0.15%
-20.0%
Q4 2017$1,405,000
-50.5%
302,157
-24.5%
0.19%
-47.7%
Q3 2017$2,840,000
-7.6%
400,000
-5.9%
0.36%
-17.7%
Q2 2017$3,074,000
+17.4%
425,1110.0%0.44%
+6.3%
Q1 2017$2,619,000
+5.1%
425,1110.0%0.42%
-13.2%
Q4 2016$2,491,000
-99.9%
425,111
-15.0%
0.48%
+13.3%
Q3 2016$2,655,589,000
+89013.7%
500,111
+11.1%
0.42%
-20.2%
Q2 2016$2,980,000
-32.8%
450,111
-52.6%
0.53%
-40.0%
Q1 2016$4,437,000
-28.7%
950,000
-23.0%
0.88%
-6.4%
Q4 2015$6,227,000
+13.2%
1,233,000
-21.1%
0.94%
+7.3%
Q3 2015$5,502,000
+3.2%
1,563,000
+192.7%
0.88%
+37.0%
Q2 2015$5,329,000
+40.9%
534,000
+79.8%
0.64%
+0.3%
Q1 2015$3,781,000
+195.6%
297,000
+228.5%
0.64%
+72.0%
Q4 2014$1,279,000
-31.6%
90,424
-33.5%
0.37%
-32.3%
Q3 2014$1,870,000
-49.3%
136,000
-43.3%
0.55%
-50.0%
Q2 2014$3,691,000
-18.4%
240,000
-9.5%
1.10%
-19.3%
Q1 2014$4,521,000
-12.7%
265,325
-33.7%
1.36%
-33.0%
Q4 2013$5,180,000400,0002.03%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Foresite Capital Management I, LLC 1,312,006$16,990,00016.50%
VHCP Management, LLC 1,000,273$12,954,0006.97%
Cormorant Asset Management, LP 1,700,000$22,015,0006.39%
HARVEY CAPITAL MANAGEMENT INC 890,500$11,531,0004.76%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 859,672$11,133,0002.50%
Rhenman & Partners Asset Management AB 400,000$5,180,0002.03%
SECTORAL ASSET MANAGEMENT INC 2,758,950$35,728,0001.54%
NORTHPOINTE CAPITAL LLC 1,289,711$16,701,0001.47%
Knoll Capital Management, LLC 200,000$2,592,0001.30%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,483,260$19,208,0001.00%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders